Population Health Sciences

You are here

Publications

Found 388 results

Author Title [ Type

] Year

Filters: First Letter Of Last Name is S [Clear All Filters]

Journal Article

Vest JR, Kern LM, Jung H-Y, Ancker JS, Richardson JE, Silver MD, Kaushal R. 2015. Patient-centered medical homes: observable types derived from national recognition assessment scores.. J Ambul Care Manage. 38(2):144-52.

Kern LM, Grinspan Z, Shapiro JS, Kaushal R. 2017. Patients' Use of Multiple Hospitals in a Major US City: Implications for Population Management.. Popul Health Manag. 20(2):99-102.

Hearld LR, Alexander JA, Shi Y, Casalino LP. 2014. Pay-for-performance and public reporting program participation and administrative challenges among small- and medium-sized physician practices.. Med Care Res Rev. 71(3):299-312.

Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al.. 2020. Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, Mendelsohn J, Moody J. 2015. Physician Networks and Ambulatory Care-sensitive Admissions.. Med Care. 53(6):534-41.

Shortell SM, McClellan SR, Ramsay PP, Casalino LP, Ryan AM, Copeland KR. 2014. Physician practice participation in accountable care organizations: the emergence of the unicorn.. Health Serv Res. 49(5):1519-36.

Richardson JE, Kern LM, Silver M, Jung H-Y, Kaushal R. 2016. Physician Satisfaction in Practices That Transformed Into Patient-Centered Medical Homes: A Statewide Study in New York.. Am J Med Qual. 31(4):331-6.

Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS et al.. 2015. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.. Stroke. 46(1):91-7.

Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS et al.. 2015. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.. Stroke. 46(1):91-7.

Press MJ, Gerber LM, Peng TR, Pesko MF, Feldman PH, Ouchida K, Sridharan S, Bao Y, Barron Y, Casalino LP. 2015. Post-Discharge Communication Between Home Health Nurses and Physicians: Measurement, Quality, and Outcomes.. J Am Geriatr Soc. 63(7):1299-305.

Bao Y, Eggman AA, Richardson JE, Sheeran TF, Bruce ML. 2015. Practices of Depression Care in Home Health Care: Home Health Clinician Perspectives.. Psychiatr Serv. 66(12):1365-8.

Hildick-Smith GJ, Pesko MF, Shearer L, Hughes JM, Chang J, Loughlin GM, Ipp LS. 2015. A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population.. J Adolesc Health. 57(6):574-9.

Grinspan ZM, Shapiro JS, Abramson EL, Hooker G, Kaushal R, Kern LM. 2015. Predicting frequent ED use by people with epilepsy with health information exchange data.. Neurology. 85(12):1031-8.

Das LT, Abramson EL, Stone AE, Kondrich JE, Kern LM, Grinspan ZM. 2017. Predicting frequent emergency department visits among children with asthma using EHR data.. Pediatr Pulmonol. 52(7):880-890.

Adekkanattu P, Rasmussen LV, Pacheco JA, Kabariti J, Stone DJ, Yu Y, Jiang G, Luo Y, Brandt PS, Xu Z et al.. 2023. Prediction of left ventricular ejection fraction changes in heart failure patients using machine learning and electronic health records: a multi-site study.. Sci Rep. 13(1):294.

Meinhofer A, Williams ARobin, Johnson P, Schackman BR, Bao Y. 2019. Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events? J Subst Abuse Treat. 105:37-43.

Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HAlan, Schackman BR. 2016. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.. Health Aff (Millwood). 35(6):1045-51.

Kennel PJ, Kneifati-Hayek J, Bryan J, Banerjee S, Sobol I, Lachs MS, Safford MM, Goyal P. 2019. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).. BMC Cardiovasc Disord. 19(1):76.

Kennel PJ, Kneifati-Hayek J, Bryan J, Banerjee S, Sobol I, Lachs MS, Safford MM, Goyal P. 2019. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).. BMC Cardiovasc Disord. 19(1):76.

Ponirakis G, Elhadd T, Chinnaiyan S, Dabbous Z, Siddiqui M, Al-Muhannadi H, Petropoulos IN, Khan A, Ashawesh KAE, Dukhan KMO et al.. 2020. Prevalence and management of diabetic neuropathy in secondary care in Qatar.. Diabetes Metab Res Rev. 36(4):e3286.